双中心应用Neuroform Atlas支架辅助弹簧圈栓塞宽颈颅内动脉瘤的经验
回顾性纳入2015年7月至2019年12月两中心112例患者共119个宽颈颅内动脉瘤,采用Neuroform Atlas支架辅助弹簧圈栓塞,术后完全闭塞率83.2%,3-6个月和12个月随访完全闭塞率分别为75.2%和81.3%,血栓栓塞和出血并发症率分别为1.7%和0.8%,作者认为该技术安全有效。
要点
- 术后即刻完全闭塞率83.2%(99/119),12个月随访完全闭塞率81.3%(74/91)。
- 75.6%的病例(90/119)使用单根微导管完成支架植入和弹簧圈栓塞。
- 血栓栓塞(支架内血栓)并发症率1.7%(2/119),出血并发症率0.8%(1/119)。
核心结论
- 使用Neuroform Atlas支架辅助弹簧圈栓塞治疗宽颈颅内动脉瘤具有较高的血管造影和临床成功率,是一种安全有效的选择。
- 大多数手术不需要使用两根微导管。
- 作者认为前瞻性对比研究可能有助于明确该技术在不断增多的宽颈动脉瘤治疗选择中的价值。
研究设计与样本
- 回顾性分析2015年7月至2019年12月两中心所有意图使用Neuroform Atlas支架行支架辅助弹簧圈栓塞的颅内动脉瘤。
- 共纳入112例患者的119个动脉瘤,其中8个为急性破裂动脉瘤。
- 分析包括所有随访检查的血管造影和临床结果。
诊断标准与关键数值
- 术后即刻完全闭塞率为83.2%(99/119)。
- 3-6个月随访完全闭塞率为75.2%(79/105)。
- 12个月随访完全闭塞率为81.3%(74/91)。
- 19例(16.0%)在初次未能重新穿过支架后于第二次手术中进行了动脉瘤再置管。
- 75.6%的病例(90/119)使用单根微导管完成支架植入和弹簧圈栓塞。
临床应用与阅片要点
- 作者认为Neuroform Atlas支架辅助弹簧圈栓塞是治疗宽颈颅内动脉瘤的安全有效选择,具有较高的血管造影和临床成功率。
- 作者指出大多数手术不需要使用两根微导管。
- 作者认为前瞻性对比研究可能有助于明确该技术在宽颈动脉瘤治疗选择中的价值。
局限性
- 作者认为前瞻性对比研究可能有助于明确该技术在不断增多的宽颈动脉瘤治疗选择中的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Stent-assisted coiling (SAC) represents an established treatment option for broad-based intracranial aneurysms. Here we report our initial and follow-up experience with the Neuroform Atlas Stent, a hybrid open- and closed-cell low-profile stent in the treatment of broad-based aneurysms.
METHODS: All intracranial aneurysms treated by SAC with the intention to apply the Neuroform Atlas Stent between July 2015 and December 2019 were included. Angiographic and clinical results were analyzed including all follow-up examinations.
RESULTS: A total of 119 aneurysms (8 acutely ruptured) in 112 patients were included. In 19 cases (16.0%) re-catheterization of the aneurysm was performed in a second procedure after failure to re-cross the stent initially. Of all aneurysms, 83.2% (99/119) were completely occluded following the procedure. In 75.6% of all cases (90/119), a single microcatheter was used for both, implantation of the stent and coil occlusion of the aneurysm. At 3-6 and 12 months follow-up, the complete occlusion rates were 75.2 (79/105) and 81.3% (74/91). The thromboembolic (stent thrombosis) and hemorrhagic complication rate was 1.7 (2/119) and 0.8% (1/119), respectively, resulting in a procedure-related morbidity and mortality rate of 0.9 and 0.9% (1/112 patients).
CONCLUSION: SAC using the Neuroform Atlas Stent offers a safe and effective option to treat broad-based intracranial aneurysms with a high angiographic and clinical success rate. In the majority of procedures, the application of two mircocatheters is not required. Prospective comparative studies might help to identify the value of SAC using the Neuroform Atlas Stent among the growing treatment options for broad-based aneurysms.
引用
- Arslan G, Maus V, Weber W, et al. Two-center experience with Neuroform Atlas stent-assisted coil occlusion of broad-based intracranial aneurysms. Neuroradiology. 2021. PMID: 33410946. doi:10.1007/s00234-020-02602-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。